The Arcturus subvariant stems from the Omicron strain of Covid-19 and is known as XBB.1.16 since it descends from the recombinant variant XBB, which combines two sublineages of Omicron BA.2.

The COVID-19 variant, Arcturus, is a sub-variant of Omicron, also known as the XBB.1.16 strain, and has been found in 22 countries, including Singapore, Australia, the UK, and the US. Since March ...

The first recorded death of someone who has the new Arcturus strain of Covid-19 has been revealed. This variant has been described as the most transmissible yet and has a symptom which has not ...

A 'zombie star' could be resurrected on Halloween night, experts say. T Coronae Borealis, also known as the 'Blaze Star,' is expected to explode, which will illuminate a dead binary star system.

the MHLW is an important milestone for the saRNA field and the Arcturus/CSL alliance, which has candidates against other variants in phase 3 testing – including the prevailing XBB.1.5 strain ...

Arcturus Therapeutics, based in San Diego, has proprietary enabling technologies: (i) LUNAR lipid-mediated delivery, (ii) self-transcribing and replicating mRNA (STARR) technology, and (iii ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...

Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...

With current treatments and vaccines for H5N1 considered insufficient or poorly matched to circulating strains, Arcturus' sa-mRNA approach could offer a more effective solution. However ...

HC Wainwright reaffirmed a “buy” rating and issued a $63.00 price objective on shares of Arcturus Therapeutics in a research note on Monday, January 13th. Cantor Fitzgerald reiterated an ...